€ 100 Neukundenbonus sichern

Global Diabetic Neuropathic Pain API Manufacturers, Marketed and Phase III Drugs Landscape 2017-2018 - Research and Markets

Datum : 17/02/2017 @ 17h41
Quelle : Business Wire

Global Diabetic Neuropathic Pain API Manufacturers, Marketed and Phase III Drugs Landscape 2017-2018 - Research and Markets

Research and Markets has announced the addition of the "Diabetic Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Diabetic Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Diabetic Neuropathic Pain Report is to understand the market and pipeline status of the drugs around the Diabetic Neuropathic Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Diabetic Neuropathic Pain Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Diabetic Neuropathic Pain.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Diabetic Neuropathic Pain

7. Phase III Drugs for Diabetic Neuropathic Pain

8. Discontinued Drugs for Diabetic Neuropathic Pain

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/dhslzl/diabetic

Research and MarketsLaura Wood, Senior [email protected] E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Related Topics: Central Nervous System Drugs , Analgesics, Endocrine and Metabolic Disorders Drugs

Kürzlich von Ihnen besucht
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
P:33 V:de D:20170326 09:16:56